4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with concanavalin a in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Foker, JE; Sheppard, JR; Wang, T | 1 |
Butler, JM; Chan, SC; Ebertz, M; Hanifin, JM; Sobieszczuk, D; Stevens, SR | 1 |
Gabbay, RA; Lardy, HA | 1 |
3 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and concanavalin a
Article | Year |
---|---|
Rise and fall of cyclic AMP required for onset of lymphocyte DNA synthesis.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Cell Cycle; Cell Division; Concanavalin A; Cyclic AMP; DNA; Indomethacin; Lymphocyte Activation; Lymphocytes; Mice; RNA; Spleen | 1978 |
Basophil histamine release in atopic dermatitis and its relationship to disordered cyclic nucleotide metabolism.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Basophils; Carbachol; Concanavalin A; Cyclic AMP; Dermatitis, Atopic; Histamine Release; Humans; Leukocytes; Methacholine Compounds; Morphine; Phosphoric Diester Hydrolases; Stimulation, Chemical | 1985 |
Methylisobutylxanthine blocks insulin antagonism of cAMP-stimulated glycogenolysis at a site distinct from phosphodiesterase. Evidence favoring an insulin-insensitive calcium release mechanism.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 8-Bromo Cyclic Adenosine Monophosphate; Aminoquinolines; Animals; Calcium; Concanavalin A; Cyclic AMP; Glucose; Insulin; Lactates; Lactic Acid; Liver Glycogen; Male; Phenylephrine; Phenylisopropyladenosine; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Strains; Theophylline; Vasopressins | 1986 |